Luminescent probes having a phenanthridinyl antenna, and methods of use
A molecular probe for the luminescent detection of nucleotides (e.g., adenosine nucleotides) is presented. In certain embodiments, the probe can readily distinguish between the three adenosine nucleotides in buffered aqueous conditions at neutral pH, a need for the direct monitoring of enzymatic reactions converting ATP to ADP or AMP. The probe is most efficient under millimolar concentrations of ATP, which are relevant to intracellular conditions. In preferred embodiments, the long luminescence lifetime of the probe readily enables time-gating experiments.
1. A luminescent probe comprising a structure of the formula:
wherein:
each R 1 represents hydrogen, a C1-C10 hydrocarbon moiety, a halogen, or Z;
R 2 represents hydrogen or a C1-C10 hydrocarbon moiety group;
R 3 represents hydrogen, a C1-C10 hydrocarbon moiety, or a halogen;
wherein for molecules in which one or more of R 1 , R 2 , and/or R 3 represents a C1-C10 hydrocarbon moiety, two or more of R 1 , R 2 , and R 3 may optionally be joined with one another to form one or more fused rings;
n=0 or 1; and
Z represents a chelated luminescent Lanthanide (Ln) complex attached to the phenanthridine with a —C(R 5 ) 2 NHC(O)CH 2 -Lanthanide (Ln) complex linkage, wherein each R 5 independently represents hydrogen with the proviso that one R 1 =Z.
2. The luminescent probe of claim 1 wherein the chelated Lanthanide complex comprises a polyamino carboxamide chelated Lanthanide, wherein the polyamino carboxamide chelator is selected from the group consisting of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetamide (DOTAm) chelator and a diethylene triamine pentaacetamide (DTPAm) chelator.
3. The luminescent probe of claim 2 wherein Z represents a group of the Formula Z1:
wherein each R 4 and R 5 independently represent H.
4. The luminescent probe of claim 3 wherein each R 4 represents a methyl group, and each R 5 represents hydrogen.
5. The luminescent probe of claim 2 wherein Z represents a group of the Formula Z2:
wherein each R 4 and R 5 independently represent H.
6. The luminescent probe of claim 5 wherein each R 4 represents a methyl group, and each R 5 represents hydrogen.
7. The luminescent probe of claim 1 wherein the Lanthanide is selected from the group consisting of La, Ce, Pr, Nd, Pm, Sm, Eu, Tb, Dy, Ho, Er, Tm Yb, Lu, or combinations thereof.
8. The luminescent probe of claim 1 wherein:
each R 1 represents hydrogen or Z;
R 3 represents hydrogen;
n=0; and
Z represents a chelated luminescent Terbium (Tb) complex, with the proviso that one R 1 =Z.
9. The luminescent probe of claim 1 comprising a structure of the formula:
wherein M represents Tb or Eu.
10. A method of detecting a nucleoside phosphate comprising:
combining at least one nucleoside phosphate and a luminescent probe according to claim 1 in an aqueous medium; and
detecting a decrease in luminescence at one or more selected wavelengths from the luminescence of the probe at the one or more selected wavelengths in the absence of the at least one nucleoside phosphate, indicating the presence of the at least one nucleoside phosphate.
11. The method of claim 10 wherein the at least one nucleoside phosphate is selected from the group consisting of nucleoside monophosphates, nucleoside diphosphates, nucleoside triphosphates, and combinations thereof.
12. The method of claim 10 wherein the at least one nucleoside phosphate is selected from the group consisting of adenosine phosphates, guanosine phosphates, cytosine phosphates, uridine phosphates, cyclic adenosine monophosphate (cyclic AMP), 6-methyluridine phosphate, 8-bromoguanosine phosphate, thymine phosphate, and combinations thereof.
13. The method of claim 10 wherein the luminescence is measured with excitation at 280 nm to 370 nm.
14. The method of claim 10 wherein the luminescence is detected at one or more wavelengths selected from the group consisting of wavelengths of 450 to 690 nm, wavelengths of 800 to 1200 nm, or wavelengths of 1500 to 1600 nm.
15. The luminescent probe of claim 1 wherein the chelator comprises a 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid-10-acetamide (DOTA) chelator.
16. The luminescent probe of claim 15 wherein Z represents a group of the Formula Z3:
wherein each R 5 independently represent H.
17. The luminescent probe of claim 16 wherein:
each R 1 represents hydrogen or Z;
R 3 represents hydrogen;
n=0; and
Z represents a chelated luminescent Europium (Eu) complex, with the proviso that one R 1 =Z.
18. The luminescent probe of claim 17 wherein each R 5 represents hydrogen.
19. The luminescent probe of claim 1 comprising a structure of the formula:
wherein M represents Tb or Eu.
20. A method of detecting a nucleoside phosphate comprising:
combining in an aqueous medium at least one nucleoside phosphate, a first luminescent probe, and a second luminescent probe;
detecting a decrease in luminescence at one or more selected wavelengths from the luminescence of at least one of the probes at the one or more selected wavelengths in the absence of the at least one nucleoside phosphate, indicating the presence of the at least one nucleoside phosphate;
wherein the first and second luminescent probes have a structure of the formula:
wherein:
each R 1 represents hydrogen, a C1-C10 hydrocarbon moiety, a halogen, or Z;
R 2 represents hydrogen or a C1-C10 hydrocarbon moiety;
R 3 represents hydrogen, a C1-C10 hydrocarbon moiety, or a halogen;
wherein for molecules in which one or more of R 1 , R 2 , and/or R 3 represents a C1-C10 hydrocarbon moiety, two or more of R 1 , R 2 , and R 3 may optionally be joined with one another to form one or more fused rings;
n=0 or 1; and
Z represents a chelated luminescent Lanthanide (Ln) complex attached to the phenanthridine with a —C(R 5 ) 2 NHC(O)CH 2 -Lanthanide (Ln) complex linkage, wherein each R 5 independently represents hydrogen, with the proviso that one R 1 =Z;
wherein the chelated Lanthanide complex of the first luminescent probe comprises a polyamino carboxamide chelated Lanthanide, wherein the polyamino carboxamide chelator is selected from the group consisting of a 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetamide (DOTAm) chelator and a diethylene triamine pentaacetamide (DTPAm) chelator; and
wherein the chelator of the second luminescent probe comprises a 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid-10-acetamide (DOTA) chelator.